Clinical Trial Update: Dapagliflozin in Patients With Atrial Fibrillation (DAPA-AF) [Phase 3]

View source ↗

Summary

Phase 3 trial update on dapagliflozin for patients with diabetes mellitus and atrial fibrillation; recruitment is ongoing.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrial Fibrillation
• Diabetes Mellitus

Drugs mentioned

• FARXIGA (dapagliflozin)

Snippet

Sponsor: University of Oklahoma | Conditions: Diabetes Mellitus, Atrial Fibrillation | Phase 3 | Status: RECRUITING